Concepedia

Daulet Satpayev

DS

Statistics

Publications

8

Citations

1.2K

H-Index

8

Active since

2014

Affiliations

ImaginAb (United States)(Current)

University of Santa Monica

Daulet Satpayev is an author at ImaginAb (United States) specializing in oncology, cancer immunotherapy, and immunotherapy.

Publications per year

2014–2022

8

Publications

8

Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models

Pia M. Challita-Eid, Daulet Satpayev, Peng Yang et al. · Cancer Research · 2016 · 696 citations

Pharmacy, Oncology, Pharmacology +17

Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma

Amani Makkouk, Xue Yang, Taylor Barca et al. · Journal for ImmunoTherapy of Cancer · 2021 · 188 citations · Full text

Life Sciences, Immunology, Oncology +17

Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models

Kevin Nishimoto, Taylor Barca, Aruna Azameera et al. · Clinical & Translational Immunology · 2022 · 113 citations · Full text

Life Sciences, Immunology, Oncology +15

The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment

Christoph M. Griessinger, Tove Olafsen, Alessandro Mascioni et al. · Cancer Research · 2020 · 54 citations

Life Sciences, Immunology, Oncology +17

AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma

Fernando Doñate, Arthur Raitano, Kendall Morrison et al. · Clinical Cancer Research · 2015 · 47 citations

Medicine, Oncology, Pharmacology +17

1–5 of 8